Author

Michael Hardler

Institution: Mayo Clinic

Observed institution: Mayo Clinic

ORCID: 0009-0006-1059-3905

Observed ORCID: 0009-0006-1059-3905

OpenAlex ID: A5160668333

Time-of-Day of Initial Immune Checkpoint Inhibitor Administration and Its Impact on Outcomes in Metastatic Non–Small Cell Lung Cancer

2026 · Sydney E. Schultz, Riley Mohr, et al. · JCO Oncology Practice

Works count: 1

Citation count:

H-index:

I10-index: